Abstract
Activation of protein kinase C (PKC) by phorbol 12-myristate 13-acetate induced a continuous decrease in the γ-aminobutyric acid (GABA)-activated current amplitude from recombinant GABA receptors (formed by ρ1 or αβγ subunits) expressed inXenopus oocytes. This decline was due to internalization of receptors from the plasma membrane as confirmed by a decrease in surface fluorescence with green fluorescence protein-tagged receptors as well as a concomitant decrease in surface [3H]GABA binding. PMA specifically caused internalization of GABA receptors, but not neuronal acetylcholine receptors (α7 or α4β2), indicating the internalization was not a general, nonspecific phenomenon. Mutation of ρ1 PKC phosphorylation sites, identified by in vitro phosphorylation, did not prevent GABA receptor internalization, nor did coexpression of the ρ1 M3-M4 intracellular loop along with ρ1 GABA receptors. It is likely that PKC-mediated phosphorylation of other proteins, rather than ρ1 itself, was required for the internalization. Both ρ1 and αβγ receptors did not degrade after phorbol 12-myristate 13-acetate-induced internalization, but returned to the membrane surface within 24 h. These data suggest internalized receptors can exist in an intracellular compartment that can be delivered back to the plasma membrane. Thus, by regulating GABA receptor surface expression, PKC may play a key role in the regulation of GABA-mediated inhibition.
Footnotes
-
Send reprint requests to: David S. Weiss, Ph.D., Department of Neurobiology, University of Alabama School of Medicine, 1719 Sixth Ave. South CIRC 410, Birmingham, AL 35294. E-mail: dweiss{at}nrc.uab.edu
-
This study was supported by National Institutes of Health Grants NS36195 and NS35291.
- Abbreviations:
- GABA
- γ-aminobutyric acid
- CNS
- central nervous system
- PKC
- protein kinase C
- GST
- glutathioneS-transferase
- PMA
- phorbol 12-myristate 13-acetate
- GFP
- visualize green fluorescence protein
- nACh
- neuronal acetylcholine
- Received September 28, 1999.
- Accepted February 2, 2000.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|